Diabetes and Metabolism Journal

Korean Diabetes Association (대한당뇨병학회)
권호 표지
DOI QR코드

DOI QR Code

Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study

  • Li, Sen (School of Life Sciences, Beijing University of Chinese Medicine) ;
  • Wang, Jiaxin (School of Life Sciences, Beijing University of Chinese Medicine) ;
  • Zhang, Biao (Department of Epidemiology and Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College) ;
  • Li, Xinyi (School of Management, Beijing University of Chinese Medicine) ;
  • Liu, Yuan (Department of Biostatistics and Bioinformatics, Winship Cancer Institute, Emory University)
  • Received : 2018.04.11
  • Accepted : 2018.11.09
  • Published : 2019.06.30
⟨ Previous Next ⟩

Abstract

Background: To investigate whether diabetes contributes to mortality for major types of diseases. Methods: Six National Health and Nutrition Examination Survey data cycles (1999 to 2000, 2001 to 2002, 2003 to 2004, 2005 to 2006, 2007 to 2008, and 2009 to 2010) and their linked mortality files were used. A population of 15,513 participants was included according to the availability of diabetes and mortality status. Results: Participants with diabetes tended to have higher all-cause mortality and mortality due to cardiovascular disease, cancer, chronic lower respiratory diseases, cerebrovascular disease, influenza and pneumonia, and kidney disease. Confounder-adjusted Cox proportional hazard models showed that both diagnosed diabetes category (yes or no) and diabetes status (diabetes, prediabetes, or no diabetes) were associated with all-cause mortality and with mortality due to cardiovascular disease, chronic lower respiratory diseases, influenza and pneumonia, and kidney disease. No associations were found for cancer-, accidents-, or Alzheimer's disease-related mortality. Conclusion: The current study's findings provide epidemiological evidence that diagnosed diabetes at the baseline is associated with increased mortality risk due to cardiovascular disease, chronic lower respiratory diseases, influenza and pneumonia, and kidney disease, but not with cancer or Alzheimer's disease.

Keywords

Acknowledgement

This study is supported by the National Natural Science Foundation of China (Grant No. 81703942), Science Fund for Distinguished Young Scholars in BUCM (Grant No. BUCM-2019-JCRC004) and BUCM research program (to Sen Li).

References

  1. Cheng LJ, Chen JH, Lin MY, Chen LC, Lao CH, Luh H, Hwang SJ. A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients. Sci Rep 2015;5:15687. https://doi.org/10.1038/srep15687
  2. Nicholas J, Charlton J, Dregan A, Gulliford MC. Recent HbA1c values and mortality risk in type 2 diabetes. Population-based case-control study. PLoS One 2013;8:e68008. https://doi.org/10.1371/journal.pone.0068008
  3. Liu Z, Fu C, Wang W, Xu B. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients: a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes 2010;8:62. https://doi.org/10.1186/1477-7525-8-62
  4. Hirakawa Y, Ninomiya T, Kiyohara Y, Murakami Y, Saitoh S, Nakagawa H, Okayama A, Tamakoshi A, Sakata K, Miura K, Ueshima H, Okamura T; Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Research Group (EPOCH-JAPAN). Age-specific impact of diabetes mellitus on the risk of cardiovascular mortality: an overview from the evidence for Cardiovascular Prevention from Observational Cohorts in the Japan Research Group (EPOCH-JAPAN). J Epidemiol 2017;27:123-9. https://doi.org/10.1016/j.je.2016.04.001
  5. Salinero-Fort MA, San Andres-Rebollo FJ, de Burgos-Lunar C, Abanades-Herranz JC, Carrillo-de-Santa-Pau E, Chico-Moraleja RM, Jimenez-Garcia R, Lopez-de-Andres A, Gomez-Campelo P; MADIABETES Group. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: association with chronic kidney disease. J Diabetes Complications 2016;30:227-36. https://doi.org/10.1016/j.jdiacomp.2015.10.007
  6. Looker AC, Eberhardt MS, Saydah SH. Diabetes and fracture risk in older U.S. adults. Bone 2016;82:9-15. https://doi.org/10.1016/j.bone.2014.12.008
  7. Nwaneri C, Bowen-Jones D, Cooper H, Chikkaveerappa K, Afolabi BA. Falling mortality rates in type 2 diabetes mellitus in the Wirral Peninsula: a longitudinal and retrospective cohort population-based study. Postgrad Med J 2012;88:679-83. https://doi.org/10.1136/postgradmedj-2012-130877
  8. Rawshani A, Svensson AM, Zethelius B, Eliasson B, Rosengren A, Gudbjornsdottir S. Association between socioeconomic status and mortality, cardiovascular disease, and cancer in patients with type 2 diabetes. JAMA Intern Med 2016;176:1146-54. https://doi.org/10.1001/jamainternmed.2016.2940
  9. Liu L, Simon B, Shi J, Mallhi AK, Eisen HJ. Impact of diabetes mellitus on risk of cardiovascular disease and all-cause mortality: evidence on health outcomes and antidiabetic treatment in United States adults. World J Diabetes 2016;7:449-61. https://doi.org/10.4239/wjd.v7.i18.449
  10. Ito WD, Lund N, Sager H, Becker W, Wenzel U. Differential impact of diabetes mellitus type II and arterial hypertension on collateral artery growth and concomitant macrophage accumulation. Vasa 2015;44:31-41. https://doi.org/10.1024/0301-1526/a000404
  11. Balducci S, D'Errico V, Haxhi J, Sacchetti M, Orlando G, Cardelli P, Vitale M, Bollanti L, Conti F, Zanuso S, Nicolucci A, Pugliese G; Italian Diabetes and Exercise Study 2 (IDES_2) Investigators. Effect of a behavioral intervention strategy for adoption and maintenance of a physically active lifestyle: the Italian Diabetes and Exercise Study 2 (IDES_2): a randomized controlled trial. Diabetes Care 2017;40:1444-52. https://doi.org/10.2337/dc17-0594
  12. Karthik D, Vijayakumar R, Pazhanichamy K, Ravikumar S. A proteomics approach to identify the differential protein level in cardiac muscle of diabetic rat. Acta Biochim Pol 2014;61:285-93.
  13. Wan EY, Fung CS, Fong DY, Lam CL. Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus: a retrospective population-based cohort study. J Diabetes Complications 2016;30:1240-7. https://doi.org/10.1016/j.jdiacomp.2016.05.024
  14. Samefors M, Scragg R, Lanne T, Nystrom FH, Ostgren CJ. Association between serum 25(OH)D(3) and cardiovascular morbidity and mortality in people with type 2 diabetes: a community-based cohort study. Diabet Med 2017;34:372-9. https://doi.org/10.1111/dme.13290
  15. Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010;33:55-60. https://doi.org/10.2337/dc09-0880
  16. Venmans LM, Bont J, Gorter KJ, Verheij TJ, Rutten GE, Hak E. Prediction of complicated lower respiratory tract infections in older patients with diabetes. Br J Gen Pract 2008;58:564-8. https://doi.org/10.3399/bjgp08X319620
  17. Colbay G, Cetin M, Colbay M, Berker D, Guler S. Type 2 diabetes affects sleep quality by disrupting the respiratory function. J Diabetes 2015;7:664-71. https://doi.org/10.1111/1753-0407.12225
  18. Klekotka RB, Mizgala E, Krol W. The etiology of lower respiratory tract infections in people with diabetes. Pneumonol Alergol Pol 2015;83:401-8. https://doi.org/10.5603/PiAP.2015.0065
  19. Lau D, Eurich DT, Majumdar SR, Katz A, Johnson JA. Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study. Thorax 2013;68: 658-63. https://doi.org/10.1136/thoraxjnl-2012-203109
  20. American Diabetes Association. Immunization and the prevention of influenza and pneumococcal disease in people with diabetes. Diabetes Care 2000;23 Suppl 1:S91-3.
  21. Lau D, Eurich DT, Majumdar SR, Katz A, Johnson JA. Working-age adults with diabetes experience greater susceptibility to seasonal influenza: a population-based cohort study. Diabetologia 2014;57:690-8. https://doi.org/10.1007/s00125-013-3158-8
  22. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njolstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364:829-41. https://doi.org/10.1056/NEJMoa1008862
  23. Di Yacovo S, Garcia-Vidal C, Viasus D, Adamuz J, Oriol I, Gili F, Vilarrasa N, Garcia-Somoza MD, Dorca J, Carratala J. Clinical features, etiology, and outcomes of community-acquired pneumonia in patients with diabetes mellitus. Medicine (Baltimore) 2013;92:42-50. https://doi.org/10.1097/MD.0b013e31827f602a
  24. Schneider ALC, Selvin E, Sharrett AR, Griswold M, Coresh J, Jack CR Jr, Knopman D, Mosley T, Gottesman RF. Diabetes, prediabetes, and brain volumes and subclinical cerebrovascular disease on MRI: the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Diabetes Care 2017;40:1514-21. https://doi.org/10.2337/dc17-1185
  25. Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, de Boer IH. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 2013;24:302-8. https://doi.org/10.1681/ASN.2012070718
  26. Ohno K, Kuno A, Murase H, Muratsubaki S, Miki T, Tanno M, Yano T, Ishikawa S, Yamashita T, Miura T. Diabetes increases the susceptibility to acute kidney injury after myocardial infarction through augmented activation of renal Toll-like receptors in rats. Am J Physiol Heart Circ Physiol 2017;313:H1130-42. https://doi.org/10.1152/ajpheart.00205.2017
  27. Graveling AJ, Frier BM. Driving and diabetes: problems, licensing restrictions and recommendations for safe driving. Clin Diabetes Endocrinol 2015;1:8. https://doi.org/10.1186/s40842-015-0007-3
  28. Harsch IA, Stocker S, Radespiel-Troger M, Hahn EG, Konturek PC, Ficker JH, Lohmann T. Traffic hypoglycaemias and accidents in patients with diabetes mellitus treated with different antidiabetic regimens. J Intern Med 2002;252:352-60. https://doi.org/10.1046/j.1365-2796.2002.01048.x
  29. Lonnen KF, Powell RJ, Taylor D, Shore AC, MacLeod KM. Road traffic accidents and diabetes: insulin use does not determine risk. Diabet Med 2008;25:578-84. https://doi.org/10.1111/j.1464-5491.2008.02409.x
  30. Renehan AG, Yeh HC, Johnson JA, Wild SH, Gale EA, Moller H; Diabetes and Cancer Research Consortium. Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia 2012;55:1619-32. https://doi.org/10.1007/s00125-012-2526-0
  31. Gu Y, Hou X, Zheng Y, Wang C, Zhang L, Li J, Huang Z, Han M, Bao Y, Zhong W, Jia W, Cui S. Incidence and mortality risks of cancer in patients with type 2 diabetes: a retrospective study in Shanghai, China. Int J Environ Res Public Health 2016;13: E559.
  32. Best LG, Garcia-Esquinas E, Yeh JL, Yeh F, Zhang Y, Lee ET, Howard BV, Farley JH, Welty TK, Rhoades DA, Rhoades ER, Umans JG, Navas-Acien A. Association of diabetes and cancer mortality in American Indians: the Strong Heart Study. Cancer Causes Control 2015;26:1551-60. https://doi.org/10.1007/s10552-015-0648-7
  33. Pladys A, Couchoud C, LeGuillou A, Siebert M, Vigneau C, Bayat S. Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39,811 French dialyzed patients. PLoS One 2015;10:e0125089. https://doi.org/10.1371/journal.pone.0125089
  34. Charlot M, Castro-Webb N, Bethea TN, Bertrand K, Boggs DA, Denis GV, Adams-Campbell LL, Rosenberg L, Palmer JR. Diabetes and breast cancer mortality in Black women. Cancer Causes Control 2017;28:61-7. https://doi.org/10.1007/s10552-016-0837-z
  35. Luo J, Virnig B, Hendryx M, Wen S, Chelebowski R, Chen C, Rohan T, Tinker L, Wactawski-Wende J, Lessin L, Margolis K. Diabetes, diabetes treatment and breast cancer prognosis. Breast Cancer Res Treat 2014;148:153-62. https://doi.org/10.1007/s10549-014-3146-9
  36. Lee J, Giovannucci E, Jeon JY. Diabetes and mortality in patients with prostate cancer: a meta-analysis. Springerplus 2016;5:1548. https://doi.org/10.1186/s40064-016-3233-y
  37. Tan C, Mori M, Adachi Y, Wakai K, Suzuki S, Suzuki K, Hashimoto Sh, Watanabe Y, Tamakoshi A. Diabetes mellitus and risk of colorectal cancer mortality in Japan: the Japan Collaborative Cohort Study. Asian Pac J Cancer Prev 2016;17:4681-8. https://doi.org/10.22034/APJCP.2016.17.10.4681
  38. Tsujimoto T, Kajio H, Sugiyama T. Favourable changes in mortality in people with diabetes: US NHANES 1999-2010. Diabetes Obes Metab 2018;20:85-93. https://doi.org/10.1111/dom.13039
  39. Ben Assayag E, Eldor R, Korczyn AD, Kliper E, Shenhar-Tsarfaty S, Tene O, Molad J, Shapira I, Berliner S, Volfson V, Shopin L, Strauss Y, Hallevi H, Bornstein NM, Auriel E. Type 2 diabetes mellitus and impaired renal function are associated with brain alterations and poststroke cognitive decline. Stroke 2017;48:2368-74. https://doi.org/10.1161/STROKEAHA.117.017709
  40. Kalaria RN. Neurodegenerative disease: diabetes, microvascular pathology and Alzheimer disease. Nat Rev Neurol 2009;5:305-6. https://doi.org/10.1038/nrneurol.2009.72
  41. Li J, Cesari M, Liu F, Dong B, Vellas B. Effects of diabetes mellitus on cognitive decline in patients with Alzheimer disease: a systematic review. Can J Diabetes 2017;41:114-9. https://doi.org/10.1016/j.jcjd.2016.07.003
  42. Lu ZK, Li M, Yuan J, Wu J. The role of cerebrovascular disease and the association between diabetes mellitus and dementia among aged medicare beneficiaries. Int J Geriatr Psychiatry 2016;31:92-8. https://doi.org/10.1002/gps.4293
  43. Dodge HH, Chang CC, Kamboh IM, Ganguli M. Risk of Alzheimer's disease incidence attributable to vascular disease in the population. Alzheimers Dement 2011;7:356-60. https://doi.org/10.1016/j.jalz.2010.12.004

Cited by

  1. Diabetes Mellitus, Still Major Threat to Mortality from Various Causes vol.43, pp.3, 2019, https://doi.org/10.4093/dmj.2018.0102
  2. Fasting Plasma Glucose Variability and Gastric Cancer Risk in Individuals Without Diabetes Mellitus: A Nationwide Population-Based Cohort Study vol.11, pp.9, 2019, https://doi.org/10.14309/ctg.0000000000000221
  3. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study vol.91, pp.3, 2019, https://doi.org/10.23750/abm.v91i3.10214
  4. The COVID-19 pandemic and diabetes mellitus vol.5, pp.1, 2019, https://doi.org/10.5114/amsad.2020.97435
  5. Proteinuria Is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study vol.9, pp.1, 2019, https://doi.org/10.3390/jcm9010136
  6. Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1 vol.11, 2019, https://doi.org/10.3389/fphar.2020.01136
  7. Loss of Smell in COVID-19 Patients: Lessons and Opportunities vol.14, 2019, https://doi.org/10.3389/fnhum.2020.598465
  8. Risk Factors in and Long-Term Survival of Patients with Post-Transplantation Diabetes Mellitus: A Retrospective Cohort Study vol.17, pp.12, 2019, https://doi.org/10.3390/ijerph17124581
  9. Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus vol.20, 2019, https://doi.org/10.2174/1389557520666201023141326
  10. Increased Mortality Risk in People with Type 2 Diabetes Mellitus in Lithuania vol.17, pp.18, 2019, https://doi.org/10.3390/ijerph17186870
  11. Beta Cell Imaging—From Pre-Clinical Validation to First in Man Testing vol.21, pp.19, 2019, https://doi.org/10.3390/ijms21197274
  12. Diabetes mellitus and COVID-19: current issues of pathogenesis, clinic and therapy. Literature review vol.54, 2019, https://doi.org/10.18370/2309-4117.2020.54.8-21
  13. The role of dental insurance in mitigating mortality among working‐age U.S. adults with periodontitis vol.47, pp.11, 2019, https://doi.org/10.1111/jcpe.13366
  14. Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study vol.19, 2019, https://doi.org/10.1186/s12933-020-01062-z
  15. Therapeutic efficacy of umbilical cord-derived stem cells for diabetes mellitus: a meta-analysis study vol.11, pp.1, 2020, https://doi.org/10.1186/s13287-020-01996-x
  16. Assessment and Management of Diabetic Patients During the COVID-19 Pandemic vol.14, 2019, https://doi.org/10.2147/dmso.s285614
  17. Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women? vol.205, 2019, https://doi.org/10.1016/j.jsbmb.2020.105770
  18. Hospitalization costs with degludec versus glargine U100 for patients with type 2 diabetes at high cardiovascular risk: Canadian costs applied to SAEs from a randomized outcomes trial vol.24, pp.1, 2021, https://doi.org/10.1080/13696998.2021.2003804
  19. Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia vol.9, 2019, https://doi.org/10.3389/fpubh.2021.559595
  20. Traditional Uses, Pharmacological Effects, and Molecular Mechanisms of Licorice in Potential Therapy of COVID-19 vol.12, 2021, https://doi.org/10.3389/fphar.2021.719758
  21. Estimating the disease burden of Korean type 2 diabetes mellitus patients considering its complications vol.16, pp.2, 2019, https://doi.org/10.1371/journal.pone.0246635
  22. Application of Telemedicine in Diabetes Care: The Time is Now vol.12, pp.3, 2021, https://doi.org/10.1007/s13300-020-00996-7
  23. Prediabetes, Diabetes, and the Risk of All-Cause and Cause-Specific Mortality in a Japanese Working Population: Japan Epidemiology Collaboration on Occupational Health Study vol.44, pp.3, 2021, https://doi.org/10.2337/dc20-1213
  24. Ameliorative potential of Operculina turpethum against streptozotocin-induced diabetes in rats: biochemical and histopathological studies vol.11, pp.6, 2021, https://doi.org/10.1007/s13205-021-02811-x
  25. Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis vol.20, pp.1, 2019, https://doi.org/10.1007/s40200-021-00768-5
  26. COVID-19 from the interdisciplinary standpoint. Round table vol.20, pp.3, 2019, https://doi.org/10.15829/1728-8800-2021-2849
  27. Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study vol.11, pp.7, 2019, https://doi.org/10.1136/bmjopen-2021-051237
  28. Diabetes is a major cause of influenza-associated mortality in Mexico vol.69, pp.4, 2021, https://doi.org/10.1016/j.respe.2021.03.009
  29. Diabetes increases the risk of COVID-19 in an altitude dependent manner: An analysis of 1,280,806 Mexican patients vol.16, pp.8, 2019, https://doi.org/10.1371/journal.pone.0255144
  30. Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future vol.37, pp.9, 2019, https://doi.org/10.1080/03007995.2021.1946024
  31. Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review vol.20, pp.2, 2019, https://doi.org/10.1007/s40200-021-00822-2
  32. Association of ACE I/D and PAI-1 4G/5G polymorphisms with susceptibility to type 2 diabetes mellitus vol.20, pp.2, 2019, https://doi.org/10.1007/s40200-021-00839-7
  33. Botanical Interventions to Improve Glucose Control and Options for Diabetes Therapy vol.3, pp.12, 2019, https://doi.org/10.1007/s42399-021-01034-8
  34. Antidiabetic bioactive compounds from Tetrastigma angustifolia (Roxb.) Deb and Oxalis debilis Kunth.: Validation of ethnomedicinal claim by in vitro and in silico studies vol.143, 2019, https://doi.org/10.1016/j.sajb.2021.07.023
  35. Low Levels of Influenza Vaccine Uptake among the Diabetic Population in Spain: A Time Trend Study from 2011 to 2020 vol.11, pp.1, 2019, https://doi.org/10.3390/jcm11010068
  36. Influence of glucose supplementation on biofilm formation of Candida albicans and Candida glabrata isolated from diabetic and non-diabetic individuals vol.134, 2019, https://doi.org/10.1016/j.archoralbio.2021.105339